Therefore, nsSNPs in HRAS may inhibit the MAPK/ERK pathway causing the restoration of tumor cells to a non-transformed state and increasing the activation of the ERK/MAPK signaling pathway leading to the occurrence and development of tumors [44]. The gene discussed is HRAS; the disease is neoplasm.